Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome-Reference-Cited by-同舟云学术

Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome

Published:2016-02 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lakiotaki Eleftheria,Levidou Georgia,Angelopoulou Maria K.,Adamopoulos Christos,Pangalis Gerassimos,Rassidakis George,Vassilakopoulos Theodoros,Gainaru Gabriella,Flevari Pagona,Sachanas Sotirios,Saetta Angelica A.,Sepsa Athanasia,Moschogiannis Maria,Kalpadakis Christina,Tsesmetzis Nikolaos,Milionis Vassilios,Chatziandreou Ilenia,Thymara Irene,Panayiotidis Panayiotis,Dimopoulou Maria,Plata Eleni,Konstantopoulos Konstantinos,Patsouris Efstratios,Piperi Christina,Korkolopoulou Penelope

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep21252.pdf

Reference47 articles.

1. Tiacci, E. et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 364, 2305–2315 (2011).

2. Arcaini, L. et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 119, 188–191 (2012).

3. Ewalt, M. et al. Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukemia. Hematol Oncol. 30, 190–193 (2012).

4. Laurini, J. A., Aoun, P., Iqbal, J., Chan, W. & Greiner, T. C. Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders. Am J Clin Pathol. 138, 877–883 (2012).

5. Pettirossi, V. et al. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity. Blood. 125, 1207–1216 (2015).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hairy cell leukemia 2024: Update on diagnosis, risk‐stratification, and treatment—Annual updates in hematological malignancies;American Journal of Hematology;2024-03-05

2. The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects;International Journal of Molecular Sciences;2023-09-14

3. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes;Molecular Cancer;2023-08-05

4. Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer;International Journal of Oncology;2022-02-14

5. Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis;Frontiers in Oncology;2020-12-10